NO158136C - Fremgangsmaate til fremstilling av tiadiazolderivater. - Google Patents

Fremgangsmaate til fremstilling av tiadiazolderivater.

Info

Publication number
NO158136C
NO158136C NO840929A NO840929A NO158136C NO 158136 C NO158136 C NO 158136C NO 840929 A NO840929 A NO 840929A NO 840929 A NO840929 A NO 840929A NO 158136 C NO158136 C NO 158136C
Authority
NO
Norway
Prior art keywords
tiadiazold
derivatives
procedure
preparation
tiadiazold derivatives
Prior art date
Application number
NO840929A
Other languages
English (en)
Norwegian (no)
Other versions
NO158136B (no
NO840929L (no
Inventor
Thomas Alfred Montzka
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO840929L publication Critical patent/NO840929L/no
Publication of NO158136B publication Critical patent/NO158136B/no
Publication of NO158136C publication Critical patent/NO158136C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO840929A 1983-03-16 1984-03-12 Fremgangsmaate til fremstilling av tiadiazolderivater. NO158136C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/475,985 US4440933A (en) 1983-03-16 1983-03-16 Process for preparing 1,2,5-thiadiazoles

Publications (3)

Publication Number Publication Date
NO840929L NO840929L (no) 1984-09-17
NO158136B NO158136B (no) 1988-04-11
NO158136C true NO158136C (no) 1988-07-20

Family

ID=23890020

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840929A NO158136C (no) 1983-03-16 1984-03-12 Fremgangsmaate til fremstilling av tiadiazolderivater.

Country Status (14)

Country Link
US (1) US4440933A (sh)
KR (1) KR860002036B1 (sh)
CA (1) CA1207763A (sh)
CS (1) CS241072B2 (sh)
DD (1) DD218364A5 (sh)
DK (1) DK155984A (sh)
ES (1) ES8602721A1 (sh)
FI (1) FI79848C (sh)
GR (1) GR81826B (sh)
HU (1) HU198925B (sh)
IE (1) IE57306B1 (sh)
LU (1) LU85254A1 (sh)
NO (1) NO158136C (sh)
YU (1) YU45597B (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578471A (en) * 1982-03-29 1986-03-25 Bristol-Myers Company Substituted amino alkyl pyridyl ethanediimidamides
US4588826A (en) * 1982-03-29 1986-05-13 Bristol-Myers Company Ethanediimidamide intermediates
US4600779A (en) * 1982-03-29 1986-07-15 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4595758A (en) * 1982-03-29 1986-06-17 Bristol-Myers Company Ethanediimidamide intermediates
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4692531A (en) * 1984-06-22 1987-09-08 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
CA1275097A (en) * 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives
DE3513184A1 (de) * 1985-04-12 1986-10-16 Ludwig Heumann & Co GmbH, 8500 Nürnberg 1,3,4-thiadiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5248673A (en) * 1992-12-23 1993-09-28 Bristol-Myers Squibb Co. Bisamidine derivatives as thrombin inhibitors
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
US4380639A (en) * 1981-03-03 1983-04-19 Bristol-Myers Company Substituted 1,2,5-thiadiazole derivatives
US4380638A (en) * 1981-03-03 1983-04-19 Bristol-Myers Company Chemical compounds

Also Published As

Publication number Publication date
CS241072B2 (en) 1986-03-13
NO158136B (no) 1988-04-11
DK155984D0 (da) 1984-03-14
ES530590A0 (es) 1985-12-01
CS185984A2 (en) 1985-06-13
CA1207763A (en) 1986-07-15
FI841009A (fi) 1984-09-17
US4440933A (en) 1984-04-03
LU85254A1 (de) 1984-11-14
DK155984A (da) 1984-09-17
FI79848C (fi) 1990-03-12
GR81826B (sh) 1984-12-12
KR860002036B1 (ko) 1986-11-17
YU46984A (en) 1986-10-31
FI79848B (fi) 1989-11-30
HU198925B (en) 1989-12-28
IE840651L (en) 1984-09-16
NO840929L (no) 1984-09-17
IE57306B1 (en) 1992-07-15
ES8602721A1 (es) 1985-12-01
KR840008005A (ko) 1984-12-12
YU45597B (sh) 1992-07-20
FI841009A0 (fi) 1984-03-13
DD218364A5 (de) 1985-02-06

Similar Documents

Publication Publication Date Title
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
NO832701L (no) Fremgangsmaate til fremstilling av metylen-difosfonsyre-derivater.
NO165911C (no) Fremgangsmaate for fremstilling av syntesegass.
NO841657L (no) Fremgangsmaate for fremstilling av ergolinderivater.
NO158136C (no) Fremgangsmaate til fremstilling av tiadiazolderivater.
NO820959L (no) Fremgangsmaate til fremstilling av acyl-kinolinonderivater
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
NO822634L (no) Fremgangsmaate for fremstilling av cefemderivater.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO166038C (no) Fremgangsmaate til fremstilling av carbapenemderivater.
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO162023C (no) Fremgangsmaate til fremstilling av antracyklinderivater.
NO845071L (no) Fremgangsmaate til fremstilling av ferromangan.
ES533618A0 (es) Procedimiento de preparacion de nuevos derivados de guarnina.
NO883145L (no) Fremgangsmaate til fremstilling av tienoimidazol-derivater.
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
ES517428A0 (es) Procedimiento de preparacion de derivados bencilidenicos.
NO159268C (no) Fremgangsmaate for fremstilling av 3-pikolin.
NO821997L (no) Fremgangsmaate for fremstilling av prolin-derivater.
NO844183L (no) Fremgangsmaate til fremstilling av bis-dioksopiperazinderivater
NO883610D0 (no) Fremgangsmaate til fremstilling av substituerte tienoimidazol-derivater.